PhotoPharmics Inc.


PhotoPharmics is a clinical-stage medical device company dedicated to developing next-generation treatments for neurodegenerative disorders through specialized phototherapy. With over 30 years of research and experience, the company focuses on innovative, non-invasive therapies to improve the lives of patients with conditions like Parkinson’s disease, Alzheimer’s, and other neurodegenerative diseases. Their approach involves specialized light solutions that regulate circadian rhythms and target neural systems, aiming for safe and effective treatments that address both motor and non-motor symptoms. PhotoPharmics is actively conducting clinical trials, including pivotal Phase 3 studies, to validate their therapies and aims to become a standard of care in neurodegenerative disease management.

Industries

biotechnology
health-care
life-science
medical
medical-device
pharmaceutical

Nr. of Employees

small (1-50)

PhotoPharmics Inc.

American Fork, Utah, United States, North America


Products

Home-use ophthalmic phototherapy device for neurodegenerative disorders

A non-invasive, tabletop ocular phototherapy device designed for daily passive home use to deliver controlled light bandwidths, intensities, and timing aimed at improving motor and non-motor symptoms via retinal stimulation and circadian modulation.


Services

Decentralized pivotal clinical trial execution

Design and conduct of fully remote, at-home pivotal device trials including participant recruitment, device distribution, virtual visits, remote assessments, and data collection.

Clinical research collaboration and scientific advisory support

Partnerships with academic centers and advisory board experts to develop trial protocols, refine endpoints, and present findings at scientific meetings.

Patient and caregiver education and engagement

Provision of educational materials, community resources, and support content aimed at patients and caregivers to improve trial awareness, recruitment, and retention.

Expertise Areas

  • Decentralized clinical trial management for medical devices
  • Randomized controlled trial design and execution
  • Phototherapy and circadian-modulation research for neurodegenerative diseases
  • Clinical endpoint selection and biostatistical planning
  • Show More (5)

Key Technologies

  • Ophthalmic phototherapy and controlled light delivery
  • Telemedicine and remote assessment platforms
  • Digital outcome capture tools and online recruitment funnels
  • Clinical motor and quality-of-life outcome instruments (e.g., standardized PD scales)
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.